Infinity Pharmaceuticals (INFIQ) Stock Statistics & Valuation Metrics

Infinity Pharmaceuticals has a market cap or net worth of $91.00. The enterprise value is ―.

Infinity Pharmaceuticals has 90,761,080 shares outstanding. The number of shares has decreased by -2.65% in one year.

Infinity Pharmaceuticals’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Infinity Pharmaceuticals is -1.12. Infinity Pharmaceuticals’s PEG ratio is 0.20.

In the last 12 months, Infinity Pharmaceuticals had revenue of 2.59M and earned -44.37M in profits. Earnings per share was -0.50.

In the last 12 months, operating cash flow was -38.88M and capital expenditures 0.00, giving a free cash flow of -38.88M billion.

Infinity Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―

Infinity Pharmaceuticals upcoming earnings date is Mar 14, 2024, TBA Not Confirmed.

Infinity Pharmaceuticals as a current ratio of 2.96, with Debt / Equity ratio of -4.81%

In the past 12 months, Infinity Pharmaceuticals has paid 0.00 in taxes.

Infinity Pharmaceuticals EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Infinity Pharmaceuticals has $17.75M in cash and marketable securities with $777.00K in debt, giving a net cash position of -$17.11M billion.

Gross margin is 39.72%, with operating margin of -1729.43%, and net profit margin of -1711.11%.

The average price target for Infinity Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―